[Should we modify hemoglobin targets in CKD patients? FDA and EMEA statements]

Nefrologia. 2007;27(4):399-404.
[Article in Spanish]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anemia / blood
  • Anemia / etiology
  • Anemia / therapy
  • Chronic Disease
  • Europe
  • Hemoglobins / analysis*
  • Humans
  • Kidney Diseases / blood*
  • Kidney Diseases / complications
  • Kidney Diseases / therapy
  • Organizations
  • United States
  • United States Food and Drug Administration

Substances

  • Hemoglobins